Cryogenx raises £1.7M seed round to tackle heat stress. The funding will drive FDA clearance and scale up manufacturing and sales.
Jul 15, 2025•18 days ago
Amount Raised
£1.7 Million
Round Type
seed
Investors
Uki2 S
Description
Cryogenx’s CGX1 offers rapid treatment for heat-related illness without the need for refrigeration. They aim to transform heat injury prevention across military and civilian sectors. The funding will support FDA clearance and expanded international sales. This innovation addresses a critical global challenge in operational safety.
Funding Insights
Based on industry dataVC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers